HUP0101514A2 - Készítmény és eljárás gyulladásos bélbetegség kezelésére N-acetilglükózamin vastagbélbe történő adagolásával - Google Patents

Készítmény és eljárás gyulladásos bélbetegség kezelésére N-acetilglükózamin vastagbélbe történő adagolásával

Info

Publication number
HUP0101514A2
HUP0101514A2 HU0101514A HUP0101514A HUP0101514A2 HU P0101514 A2 HUP0101514 A2 HU P0101514A2 HU 0101514 A HU0101514 A HU 0101514A HU P0101514 A HUP0101514 A HU P0101514A HU P0101514 A2 HUP0101514 A2 HU P0101514A2
Authority
HU
Hungary
Prior art keywords
acetylglucosamine
composition
inflammatory bowel
bowel disease
treatment
Prior art date
Application number
HU0101514A
Other languages
English (en)
Inventor
Ian W. French
Simon Murch
Original Assignee
Glucogenics Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glucogenics Pharmaceuticals Inc. filed Critical Glucogenics Pharmaceuticals Inc.
Priority claimed from PCT/CA1999/000218 external-priority patent/WO1999053929A1/en
Publication of HUP0101514A2 publication Critical patent/HUP0101514A2/hu
Publication of HUP0101514A3 publication Critical patent/HUP0101514A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)

Abstract

A találmány tárgya készítmény gyulladásos bélbetegség kezelésére,gyulladásos bélbetegségben szenvedő betegben, amely (a) terápiásmennyiségű N-acetilglükózamint és (b) az N-acetilglükózaminnak a betegbeléhez történő eljuttatására, és a bélben a gyulladásos bélbetegséghelyéhez történő lokális adagolásra alkalmas, gyógyászatilagelfogadható és a béllel összeférhető hordozóanyagot tartalmaz. Atalálmány további tárgya N-acetilglükózamin alkalmazása gyulladásosbélbetegség kezelésére alkalmas gyógyszer előállítására. Ó
HU0101514A 1998-04-17 1999-03-12 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine HUP0101514A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002234936A CA2234936C (en) 1998-04-17 1998-04-17 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
PCT/CA1999/000218 WO1999053929A1 (en) 1998-04-17 1999-03-12 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine

Publications (2)

Publication Number Publication Date
HUP0101514A2 true HUP0101514A2 (hu) 2001-11-28
HUP0101514A3 HUP0101514A3 (en) 2003-07-28

Family

ID=4162337

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101514A HUP0101514A3 (en) 1998-04-17 1999-03-12 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine

Country Status (8)

Country Link
EP (1) EP1071432A1 (hu)
JP (1) JP2002512195A (hu)
CA (1) CA2234936C (hu)
CZ (1) CZ20003846A3 (hu)
HU (1) HUP0101514A3 (hu)
IL (1) IL139072A0 (hu)
NO (1) NO20005223L (hu)
PL (1) PL343634A1 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2918452T3 (es) 2007-02-19 2022-07-15 Marine Polymer Tech Inc Composiciones hemostáticas y regímenes terapéuticos
KR101098581B1 (ko) * 2009-01-09 2011-12-26 서울대학교산학협력단 Ａｂｈ 항원을 이용한 염증질환 개선용 조성물
WO2011130646A1 (en) 2010-04-15 2011-10-20 Marine Polymer Technologies, Inc. Anti-bacterial applications of poly -n-acetylglucosamine nanofibers
JP6144254B2 (ja) 2011-04-15 2017-06-07 マリン ポリマー テクノロジーズ，インコーポレーテッド ポリ−ｎ−アセチルグルコサミンナノファイバを用いた疾患の治療
US9539265B2 (en) 2013-03-15 2017-01-10 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
WO2014142938A1 (en) * 2013-03-15 2014-09-18 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
CA2967722A1 (en) * 2014-11-26 2016-06-02 Evonik Rohm Gmbh Pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
KR102104507B1 (ko) * 2019-08-23 2020-04-24 브릿지바이오테라퓨틱스(주) 팔미토일-l-프롤릴-l-프롤릴-글리실-l-타이로신 나트륨을 포함하는 약제학적 제제 및 이의 제조방법

Also Published As

Publication number Publication date
CA2234936A1 (en) 1999-10-17
IL139072A0 (en) 2001-11-25
NO20005223D0 (no) 2000-10-17
NO20005223L (no) 2000-11-20
JP2002512195A (ja) 2002-04-23
EP1071432A1 (en) 2001-01-31
HUP0101514A3 (en) 2003-07-28
CZ20003846A3 (cs) 2002-03-13
CA2234936C (en) 2004-06-29
PL343634A1 (en) 2001-08-27

Similar Documents

Publication Publication Date Title
IL130931A0 (en) Small molecules useful in the treatment of inflammatory disease
ZA9810444B (en) Use of 9-deoxy-2',9-methano-3-oxa-4,5,6-trinor-3,7-(1',3'interphenylene)-13,14-dihydroprostaglandin F1 to treat peripheral vascular disease
GEP20022656B (en) 2-(Purin-9-YL)-Tetrahydrofuran-3,4-Diol Derivatives
HK1042496B (zh) 新的果糖1，6-二磷酸酶的雜芳族抑制劑
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
AU1175000A (en) Local delivery of drugs to the colon for local treatment of colonic diseases
MY120235A (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives
MX9708621A (es) AGONISTAS beta-ADRENERGICOS, COMPOSICIONES QUE LOS CONTIENEN Y USO DE LOS MISMOS.
AP2001002291A0 (en) Novel method of treatment.
HUP9800467A3 (en) Use of hyaluronic acid for producing pharmaceutical compns. for the treatment of interstitial cystitis
HUP0101514A2 (hu) Készítmény és eljárás gyulladásos bélbetegség kezelésére N-acetilglükózamin vastagbélbe történő adagolásával
ATE269710T1 (de) Pharmazeutische zusammensetzung für die behandlung von enzündlichen darmerkrankungen
GR3035492T3 (en) Benzothiophene compounds
ZA973622B (en) Use of forms of hyaluronic acid (HA) for the treatment of cancer.
MXPA03001081A (es) Medicamento anti-inflamatorio.
AU6425800A (en) Agents for the diagnosis, prognosis and treatment of malignant diseases
JPH0784481B1 (hu)
NZ509348A (en) Use of a somatostatin analogue Lanreotide
IL159070A0 (en) Use of corrinoids in the treatment of skin diseases
EP0831869A4 (en) DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS
GB9420747D0 (en) 1,5 benzodiazepine derivatives
WO2002067851A3 (en) Method for treating fibrotic diseases or other indications iiic
EP1132083A3 (en) Use of zinc tranexamate in the treatment of diabetes
ZA981558B (en) Inclusion complexes in aqueous solution
EP1197225A4 (en) AGENTS FOR DISEASES CAUSED BY PTH OR PTHrH